$11.30
0.10[0.89%]
Last update: 12:16PM Get Real Time Here
EyePoint Pharmaceuticals
(NASDAQ:EYPT)Latest News for EyePoint Pharmaceuticals Stock (NASDAQ:EYPT)
EyePoint Pharmaceuticals Stock (NASDAQ: EYPT)
Categories: All
Tuesday, May 07, 2024
Monday, May 06, 2024
- Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares PlungeAvi Kapoor - 21 hours ago
- Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On MondayAvi Kapoor - 23 hours ago
- Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 ResultsAvi Kapoor - 23 hours ago
- Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - 23 hours ago
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - 1 day ago
- Nasdaq Jumps 100 Points; Tyson Foods Sales Miss ViewsAvi Kapoor - 1 day ago
- EyePoint Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Down -40.9%Benzinga Newsdesk - 1 day ago
- Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?Vandana Singh - 1 day ago
- Market-Moving News for May 6thBenzinga Newsdesk - 1 day ago
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - 1 day ago
- EyePoint Pharmaceuticals shares are trading lower after the company's Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.Benzinga Newsdesk - 1 day ago
- EyePoint Pharmaceuticals Announces Announces Phase 2 PAVIA Trial Of DURAVYU Did Not Meet Pre-Specified Primary EndpointBenzinga Newsdesk - 1 day ago
- Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - 1 day ago
- EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU in Non-Proliferative Diabetic RetinopathyBenzinga Newsdesk - 1 day ago
- Trading Halt: Halted at 6:55:38 a.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - 1 day ago
Tuesday, April 23, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
- Eyepoint Pharmaceuticals Expect That Cash, Cash Equivalents, And Investments On December 31, 2023 Of $331M, Will Provide Cash Runway Through Planned Phase 3 Trials Of EYP-1901 For Wet AMD In 2026Benzinga Newsdesk - Mar 7, 2024, 7:04AM
- EyePoint Pharmaceuticals Q4 GAAP EPS $(0.33) Beats $(0.49) Estimate, Sales $14.03M Beat $8.90M EstimateBenzinga Newsdesk - Mar 7, 2024, 7:03AM
- Earnings Scheduled For March 7, 2024Benzinga Insights - Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
Monday, March 04, 2024
Friday, February 16, 2024
Monday, February 12, 2024
Sunday, February 04, 2024
- EyePoint Pharmaceuticals Says The Trial Met Its Primary Endpoint With Both EYP-1901 Doses Demonstrating Statistical Non-Inferiority Change In Best Corrected Visual Acuity; The Trial Also Achieved Key Secondary EndpointBenzinga Newsdesk - Feb 4, 2024, 1:38PM
- EyePoint Pharmaceuticals Announces Two Presentations Of Topline Data With Additional Subgroup Analyses From The Phase 2 DAVIO 2 Clinical Trial Of EYP-1901 For The Treatment Of Wet Age-Related Macular DegenerationBenzinga Newsdesk - Feb 4, 2024, 1:37PM
Monday, January 22, 2024
Tuesday, January 16, 2024
Friday, January 12, 2024
Thursday, January 11, 2024
Wednesday, January 10, 2024
Tuesday, December 19, 2023
Wednesday, December 13, 2023
Monday, December 11, 2023
Friday, December 08, 2023
Thursday, December 07, 2023
Wednesday, December 06, 2023
Tuesday, December 05, 2023
- 5 Analysts Have This to Say About EyePoint PharmaceuticalsBenzinga Insights - Dec 5, 2023, 3:00PM
- HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Raises Price Target to $35Benzinga Newsdesk - Dec 5, 2023, 2:33PM
- Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Dec 5, 2023, 1:06PM
- NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On TuesdayLisa Levin - Dec 5, 2023, 10:04AM
- Top 5 Health Care Stocks That Are Ticking Portfolio BombsLisa Levin - Dec 5, 2023, 9:05AM
Monday, December 04, 2023
- EyePoint Pharmaceuticals, Hut 8 Mining, GitLab, Take-Two Interactive, Tesla: Why These 5 Stocks Are On Investors' Radars TodayBenzinga Neuro - Dec 4, 2023, 9:23PM
- EyePoint Pharmaceuticals Announces Proposed $175M Public Offering Of Common StockBill Haddad - Dec 4, 2023, 4:08PM
- Crude Oil Falls Over 1%; EyePoint Pharmaceuticals Shares Spike HigherLisa Levin - Dec 4, 2023, 2:33PM